Tumor mutational burden and response to programmed cell death protein 1 inhibitors in a case series of patients with metastatic desmoplastic melanoma.
Boussemart, Lise MD, PhD a,b; Johnson, Adrienne MSc c; Schrock, Alexa B. PhD, MD c; Pal, Sumanta K. MD d; Frampton, Garrett M. PhD c; Fabrizio, David BS c; Chalmers, Zachary c; Lotem, Michal MD e; Gibney, Geoffrey MD f; Russell, Jeffery MD g; Chmielowski, Bartosz MD, PhD h; Ross, Jeffrey S. MD c,i; Stephens, Phil J. PhD c; Miller, Vincent A. MD c; Ali, Siraj M. MD, PhD c,*
Journal of the American Academy of Dermatology.
80(6):1780-1782, June 2019.
(Format: HTML, PDF)